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and tomatoes/lycopene. Overall consumption 
of meat, eggs, vegetables, fruit, coffee, tea, 
carotenoids and vitamins A, C and D was not 
consistently related to prostate cancer risk. 
Intervention studies also indicate that 
supplementation with 
 
b
 
-carotene does not 
lower prostate cancer risk, except possibly in 
men with low 
 
b
 
-carotene status at baseline. 
For specific types of meat, alcoholic drinks, 
dairy products, fat and anthropometric 
measures, most cohort studies suggest either 
an increased risk or no relation with prostate 
cancer. For calcium, two cohort studies 
suggest an increased risk at very high calcium 
intakes (>2000 mg/day). In conclusion, 
prospective studies are consistent with a 
protective role for selenium, and possibly 
vitamin E, pulses and tomatoes/lycopene, in 
the aetiology of prostate cancer. Studies are 
inconclusive on the role of meat, dairy 
products, fat, vegetables, fruits, alcohol and 
anthropometric measures, whereas a very 
high calcium intake appears to be positively 
associated with prostate cancer risk.
 
ABSTRACT
 
We reviewed 37 prospective cohort and four 
intervention studies on potential dietary risk 
factors for prostate cancer, published 
between 1966 and September 2003. Some 
studies were limited by small size, crude 
measurement of dietary exposure and limited 
control for confounders. Intervention and 
prospective cohort studies support a 
protective role against prostate cancer for 
selenium, and possibly for vitamin E, pulses 
 
INTRODUCTION
 
Prostatic cancer is presently one of the most 
frequently occurring forms of cancer in 
Western countries. In Europe, and in the USA 
and Canada, the age-adjusted incidence is 
increasing [1]. Prostate cancer occurrence 
differs markedly across different populations; 
age-adjusted incidence rates of clinical 
prostate cancer of 
 
ª
 
1 per 100 000 are 
reported for China, whereas in the USA rates 
for whites are 45–65 per 100 000, and rates 
for blacks are as high as 102 per 100 000. 
Incidence rates in Western Europe are 20–30 
per 100 000, with some variation among 
countries [2]. Mortality rates have not 
changed markedly during the past century [1]. 
In contrast to clinical prostate cancer 
incidence, which varies geographically, latent 
prostate carcinomas seem to be equally 
distributed across areas with high and low 
total prostate cancer incidence rates [3–5], 
supporting the view that environmental 
factors may be important in the progression 
from latent to clinical prostate carcinoma.
Dietary factors are among the environmental 
variables which may be important in the 
causes of prostate cancer. Since 1980 many 
reviews on the relation between dietary 
factors and prostate cancer have been 
published, e.g. [6–11], but the scope of most 
reviews was limited in the number of dietary 
risk factors, the broadness of dietary 
categories, and/or the completeness of 
included studies.
The present review discusses both 
methodological issues and results on 
individual foods/nutrients; it is limited to 
prospective cohort and intervention studies, 
as such studies are less prone to bias than, e.g. 
case-control and ecological studies.
 
METHODS
 
Published papers were searched using 
Medline/Pubmed (the computerized database 
from the Index Medicus) using the keywords 
‘epidemiology’, ‘etiology’, ‘diet’, ‘risk factor’, 
‘cohort’, and ‘study’, all combined with 
‘prostatic neoplasms’. Furthermore, references 
in the selected publications were checked for 
relevant publications not included in the 
Medline/Pubmed search. Studies included in 
this review are prospective cohort and 
intervention studies published between 1966, 
the earliest year covered by Medline, and 
September 2003. Only studies in which 
dietary intake was measured by blood 
biomarkers, questionnaires or interviews are 
included. Dietary factors described include 
vegetables, fruit, meat, fish, milk and dairy 
products, eggs, coffee, tea, vitamins, fat, fatty 
acids, selenium and alcohol. In addition, 
prospective studies on anthropometric 
measures as a risk factor for prostate cancer 
are reviewed. In most cases, reported risk 
ratios are adjusted for age but not for other 
risk factors, as this information was not 
available in most publications. Items are 
considered to be positively or negatively 
associated with prostate cancer risk when the 
relative risk (RR) estimate for the highest vs 
lowest exposure category was <0.8 (decrease) 
or >1.2 (increase). 
 
P
 
 < 0.05 was considered to 
indicate statistical significance.
 
RESULTS
 
Four randomized, placebo-controlled 
intervention studies [12–17] were identified, 
three in the USA [12–15,17] and one in 
Finland [16] (Table 1). The following 
supplements were studied in these trials: 
 
b
 
-carotene [12–14]; 
 
b
 
-carotene with/without 
vitamin E, in a factorial design [16]; 
 
b
 
-
carotene with retinol [17], and selenium [15]. 
In three of these four trials prostatic cancer 
was a secondary outcome measure; two trials 
were in subjects at high risk of developing 
lung cancer [16,17] and one in subjects at 
high risk of basal/squamous cell carcinoma of 
the skin [15].
In all, 37 prospective cohort studies (including 
reports of prospective cohort analyses within 
intervention studies) were identified; 17 of 
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these studies had used biomarkers in blood or 
toenails [18–52] as indicators of dietary 
intake, with or with no dietary questionnaires 
(Table 2), whereas 20 studies had used dietary 
questionnaires or interviews only [41,53–80] 
(Table 3). Baseline measurements in most of 
the cohort studies had been taken before 
1980. The cohort size varied from 974 [15] to 
450 279 men [71]. Reports of eight studies 
included >400 cases [12–14,37,42–46,49–
54,72–80], whereas eight included <50 cases 
[15,18–21,23,25,28,36] and another seven 
50–100 cases [26,27,55,58,63,67,70]. The 
largest number of cases to date is 3811 [80]. In 
24 studies incidence was used as an endpoint, 
in eight mortality and in nine both incidence 
and mortality. Most reports did not mention 
whether the concerned dietary questionnaire 
had been validated; only reports on the Health 
Professionals Follow-Up Study [41,72–79], the 
Netherlands Cohort Study on Diet and Cancer 
[42–45,49,51], the cohort-based part of the 
Alpha-Tocopherol Beta-Carotene Cancer 
Prevention Study (ATBC Study) [40,47], the 
Cancer Prevention Study II Nutrition Cohort 
[80], and a Norwegian study [67] mentioned 
that the questionnaire used had been 
validated. These five studies had used 
relatively extensive dietary questionnaires 
(68–276 items).
In Tables 4–6 results from intervention and 
cohort studies on dietary risk factors for 
prostate cancer are summarized. A RR of 1 
indicates null association, >1 a positive 
association (i.e. increased risk), and <1 a 
negative association (i.e. reduced risk/
protective effect). Table 4 gives results from 
four published trials on 
 
b
 
-carotene, retinol, 
vitamin E and selenium. In the ATBC Study 
[16] and the Physicians’ Health Study 
(PHS) [12–14], there was no effect of 
supplementation with 
 
b
 
-carotene. The 
ATBC study was performed in smokers 
and the PHS both smokers and nonsmokers. 
Within the PHS the effect of 
 
b
 
-carotene 
supplementation on prostate cancer 
incidence was similar in smokers and 
nonsmokers (both RR = 1.0) [12]. However, 
 
b
 
-
carotene supplementation seemed to reduce 
prostate cancer incidence in subjects with low 
baseline plasma 
 
b
 
-carotene levels (RR = 0.68, 
Table 4), but to increase prostate cancer 
incidence in subjects with high baseline levels 
(RR = 1.33) [13]. The Beta-Carotene and 
Retinol Efficacy Trial showed no effect of 
supplementation with 
 
b
 
-carotene and retinol 
in smokers [17].
Significantly reduced risks were reported for 
on supplementation with vitamin E in the 
ATBC Study in smokers [16], and for selenium 
in the Nutritional Prevention of Cancer Trial in 
subjects at high risk of developing basal/
squamous cell carcinoma of the skin [15].
Results from prospective cohort studies with 
blood or toenail samples as biomarkers are 
also shown in Table 4, and from studies with 
questionnaires in Table 5. For vitamin A/
retinol the results were inconsistent; three 
cohort studies with blood samples showed a 
decreased risk of prostate cancer [26–28], one 
showed no association [20] and five showed 
an increased risk [19,21,25,36,46]. In 
questionnaire-based studies of vitamin 
A/retinol intake, five null associations 
[51,60,69,71,78], one negative [51] and one 
positive [78] association were reported.
For carotenoids, serum-based studies showed 
a reduced prostate cancer risk for 
 
a
 
-carotene 
[46]; no effect [26] or an increased risk [25] 
for 
 
b
 
-carotene, and no association for 
 
b
 
-
cryptoxanthin [46]. In questionnaire-based 
studies, there was no association for 
intake of 
 
a
 
-carotene [51,78] 
 
b
 
-carotene 
[51,56,60,69,78], or lutein/zeaxanthin [51,78]; 
for 
 
b
 
-cryptoxanthin, one study showed no 
effect [78] and one a significantly increased 
risk [51]. Lycopene showed an inverse 
association with prostate cancer risk in two 
serum-based [26,46] and one questionnaire-
based [78] study, but no association in two 
other questionnaire-based studies [51,73].
Other vitamins investigated in cohort studies 
include C, D and E. Vitamin C showed no 
association with prostate cancer risk in one 
serum-based study [36]; three questionnaire-
based studies showed no association for 
vitamin C intake from supplements [51,69] or 
food [69,78], but two questionnaire-based 
studies showed an increased risk for vitamin C 
intake [51,56] and one a reduced risk for 
vitamin C from supplements [51]. For the 
vitamin D-metabolite 25-OH-D measured in 
blood samples, no association with prostate 
cancer risk was apparent [29,34], whereas 
1,25-OH-D showed either an inverse 
association [29] or no association [34] with 
 
TABLE 1 
 
Descriptive characteristics of published intervention studies on dietary risk factors for prostate cancer, according to year of baseline measurement; all 
studies used a placebo comparison.
 
Country Ref Baseline
Cohort size
(age range)*
Follow-up,
years
No. of cases
(I or D)† Design Intervention frequency Notes
USA [12–14] 1982 22 071 (40–84) 12.9 1047–1117
(I+D)
2 
 
¥ 
 
2 F
 
b
 
-carotene/P 50 mg AD
aspirin/P 325 mg AD‡
Physicians
USA [15] 1983  974 (63)¶ 6.5 48 (I) BR/t + clinic Selenium 200 mg D Patients with previous
skin cancer
Finland [16] 1985–88 29 133 (50–69) 5–8 246 (I) 2 
 
¥
 
 2 F
 
a
 
-tocopherol 50 mg D
 
b
 
-carotene 20 mg D
Smokers
USA [17] 1988 18 314 (58) 4 300 (I) Part 2 
 
¥
 
 2 F
Part 1 : 1
 
b
 
-carotene 30 mg D
25 000 IU
vitamin A D
Men at high risk of
lung cancer
 
F, factorial design; AD, alternate days; D, daily; BR, block randomization; P, placebo; *Age range of the study population; †I, incident cases, D deceased cases; 
‡Aspirin/placebo: 325 mg on alternate days from 1982 to 1988 when the aspirin/placebo intervention was terminated early because of a 44% reduction in 
incidence of first myocardial infarction by aspirin; the 
 
b
 
-carotene intervention was continued until 1995; ¶Mean age.
 D I E T ,  A N T H R O P O M E T R I C  M E A S U R E S  A N D  P R O S T A T E  C A N C E R  R I S K
 
©
 
 2 0 0 4  B J U  I N T E R N A T I O N A L
 
11 4 1
 
prostate cancer risk. In a single questionnaire-
based study, vitamin D intake showed no 
association [80].
Serum levels of vitamin E and 
 
a
 
-tocopherol 
showed a negative association with prostate 
cancer risk in three studies [19,23,48], and no 
relation in one [26]. Vitamin E intake from 
food [40,51,78] and supplements [40,69,75] 
showed no association with prostate cancer 
risk, except for one study which showed a 
reduced risk for vitamin E from supplements 
[51]. High 
 
g
 
-tocopherol levels in serum were 
associated with a significantly reduced 
prostate cancer risk (RR = 0.19) in one study 
[48].
Selenium was associated with a decreased 
prostate cancer risk in five of six biomarker-
based studies, i.e. two serum-based studies 
[21,28] and three based on selenium analysis 
of toenails [41,48,52]; only one serum-based 
study [40] showed no effect.
Calcium intake showed no association with 
prostate cancer risk in two questionnaire-
based studies [45,47]; in these, mean calcium 
intake in the highest quintile was 1330 and 
1840 mg/day, respectively. In contrast, in two 
other questionnaire-based studies [76,80], 
a calcium intake of >2000 mg/day was 
associated with a marked increase in prostate 
cancer risk; in both studies, calcium from 
food sources and from supplements were 
independently associated with increased 
prostate cancer risk.
Intake of total protein, vegetable/animal 
protein and carbohydrate were not related to 
prostate cancer risk [44,47]. For fructose, one 
study showed an inverse association with 
prostate cancer risk [76], whereas a second 
study showed no association [47]. As for fat 
and fatty acids, of 26 associations reported in 
five studies, two were negative, 14 null and 10 
positive (Table 4). Total fats and total fatty 
acids showed no association with risk of 
prostate cancer in serum-based studies 
[24,30,39], but questionnaire-based studies 
showed a tendency for a modest positive 
association between total fat consumption 
prostate cancer risk (RR = 1.1–1.3, Table 5) 
[44,47,67,79]. For saturated fat (including 
animal fat) results were inconsistent, with a 
null [24] and positive association [39] in 
two serum-based studies, and one inverse 
[67], one null [79] and two positive [44,66] 
associations in questionnaire-based studies. 
For different categorizations of unsaturated 
fat there were mostly null associations in 
serum-based studies [24,35,39], although 
one showed an inverse association for n-6 
polyunsaturated fatty acids (PUFA) [39] 
and one a positive association for mono-
unsaturated fat [39]. Questionnaire-based 
studies showed an increased risk for intake of 
mono-unsaturated fat [44,67,79] and 
polyunsaturated fat [67].
Linoleic acid and 
 
a
 
-linolenic acid are the two 
fatty acids most frequently investigated for 
the risk of prostate cancer. For linoleic acid, 
serum-based studies showed either an inverse 
association with prostate cancer risk [32] 
or no effect [39]; two questionnaire-based 
studies also showed no effect [44,79]. 
 
a
 
-
Linolenic acid was positively associated with 
prostate cancer risk in two serum-based 
 
TABLE 2 
 
Descriptive characteristics of published prospective cohort studies on prostate cancer and dietary and anthropometric risk factors measured by 
biomarkers (blood/toenails) with or without questionnaires/interviews, according to year of baseline measurement
 
Country
Ref Baseline
Cohort size
(age range)*
Follow-up,
years
No. of cases
(I or D)†
Exposure
measure
Investigated§
exposure variables
N items on
diet (alcohol)
Validation
dietary Q
USA [18] 1960–62 3 102 (>40) 12–14 8 (I + D) BS V – –
USA [29,33] 1964–71 250 000‡ (38–81) 1–23 181 (I) BS V – –
USA [22,24,31,38] 1965–68 7 999 (>65) 21–23 174–306¶ (I) BS; FFQ (interview)
24-h recall
V, 1–6, 14, A, AP  23 unknown
USA [20] 1967–69 ? 10–12 14 (I + D) BS V – –
Finland [23,25] 1968–72 36 265‡ (15–99) 8 32 (I) BS; Q V – –
Switzerland [36] 1971–73 2 974 (?) 17 30 (D) BS; Q V – –
USA [27] 1971–75 2 440 (>50) 10 84 (I + D) BS; Q; exam V – –
USA [21] 1972–76 6 167 (?) 0–10 13 (I) BS; interview V, 11 – –
USA [28] 1972–76 8 825 (>30) 8.5 6 (D) BS; interview V, 11 – –
Sweden [30] 1972–78 53 242 (20–55) 16.3 220 (I) BS; Q; exam 8, AP – –
USA [19] 1973–74 4 480 (30–69) 5 11 (I) BS V – –
Norway [39] 1973–94 ? (50) 0.4–19.2 141 (I) BS 7, 8 – –
USA [26,35,85] 1974 25 802 (?) 12? 43–103 (I) BS 8, V – –
USA [32,34,37,46,50] 1982 22 071 (40–84) 6–11 120–1 047¶ (I) BS; Q 3, 5, 8, V, 12, AP 131 unknown
Finland [40,47] 1985–93 29 133 (50–69) 7 233–317 (I) BS; FFQ V, 11, 12, 15, 276 yes
USA [41,72–79] 1986 51 529 (40–75) 6–12 300–2482 (I + D) TC; FFQ 1–8, V, AP 131 yes
Netherlands 
[42–45,49,51,52]
1986 58 279 (55–69) 6.3 704 (I) TC; FFQ 1–12, V, A, AP 150 yes
USA [48] 1986 10 456 0–7 145 (I) BS; TC; FFQ V, 11 – –
 
BS, blood sample; A, alcohol, V, vitamins; Q, questionnaire; AP, anthropometry; FFQ, food frequency questionnaire; TC, toenail clipping; *Age range of the study 
population; †I, incident cases, D deceased cases; ‡Only a total of men and women given; ¶Number of cases depending on exposure under study. § 1 vegetables, 
2 fruits, 3 meat, 4 fish, 5 dairy, 6 eggs, 7 fat, 8 fatty acids, 9, cheese, 10 protein, 11 selenium, 12 calcium, 14 coffee, 15 phosphorus.
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studies [32,39], but two questionnaire-based 
studies gave inconsistent results (one positive 
[79] and one negative [44] association). Other 
individual fatty acids were investigated in two 
serum-based [32,39] and one questionnaire-
based [44] study; there were no consistent 
associations, except for oleic acid which was 
associated with increased prostate cancer risk 
in three studies [32,39,44].
Table 6 summarizes results on foods and 
alcohol intake, measured by questionnaires or 
interviews. Consumption of total vegetables 
showed inverse associations [60,71] and null 
associations [42,47,69,78] with prostate 
cancer risk. Furthermore, there were inverse 
associations for the consumption of green 
salads [66] and pulses, including soy milk 
[42,65,66]. Three studies showed an inverse 
association between consumption of 
tomatoes/tomato sauce and prostate cancer 
risk [66,73,78], but one study showed null 
association for tomatoes and tomato juice 
[42]. In contrast, positive associations with 
prostate cancer risk were reported for 
consumption of fried vegetables [24], and 
cooked and raw spinach [78]. Cruciferous 
vegetables and broccoli showed no relation 
with prostate cancer risk in two studies 
[42,78], but a positive association in a third 
[60]. Several other (groups of) vegetables were 
investigated, e.g. green and yellow vegetables 
[59,69], raw and cooked vegetables [42], 
carrots [78], and alliums (onions, leeks, etc. 
[42]) but no association with prostate cancer 
risk was found.
Overall consumption of fruit showed no 
association with prostate cancer risk in five 
studies [58,60,66,69,78], a positive association 
in three [24,42,47], and a negative association 
in one [76]. For specific fruit items there was 
no association except for raisins, dates and 
other dried fruit, which showed a decreased 
prostate cancer risk [66], and citrus fruit/
oranges which showed null association in two 
studies [66,78] but a positive association in a 
third [42].
Overall meat consumption was not 
consistently related with prostate cancer risk; 
three studies showed an increased risk 
[58,59,66], one a decreased risk [67], and three 
no relation [24,60,74]. For consumption of 
different types of meat, including processed 
meats, most reported associations were 
positive (16) or null (19); only four studies 
showed a negative association (Table 6).
Consumption of fish showed no consistent 
relationship with prostate cancer risk: two 
studies [24,66] showed a positive and two 
[59,61] a negative association, and six 
[45,60,64,67,72,82] no effect.
Consumption of milk and dairy products was 
either positively associated (13 reported) or 
unrelated (14 reported) with the risk of 
prostate cancer; no negative associations 
were reported. For milk, two positive [58,64], 
and four null [24,59,78,82] associations were 
reported, and for whole milk, one positive 
[74] and two null [63,66]. Several studies 
suggested positive associations for 
consumption of skimmed milk [67,74]; 
cheese [58]; butter [74]; butter, margarine 
and cheese combined [24]; and ice-cream 
[24,74].
Consumption of eggs was not significantly 
related to prostate cancer risk in seven of 10 
studies [45,60,63,64,67,78,82], with a positive 
association observed in two of the remaining 
studies [24,58] and an inverse association in 
one study [66].
Coffee consumption was investigated in four 
studies [24,60,64,82]; only one showed an 
 
TABLE 3 
 
Descriptive characteristics of published prospective cohort studies on dietary risk factors for prostate cancer, measured by questionnaires or interviews, 
and anthropometric risk factors, according to year of baseline measurement
 
Country Ref Baseline
Cohort size
(age range)
Follow-up,
years
No. of cases
(I or D)
Exposure
measure
Investigated
exposure variables
N items on
diet (alcohol)
Validation
dietary Q
USA [53] 1880–1916 18 000 (CA) ? 268 (D) Measure AP – –
USA [54] 1916–50 51 477 (CA) 16–50 243 (I + D) Q; exam A, AP unknown unknown
Denmark [55] 1954–87 15 214 (?) 12.9 91 (I) Int A – –
USA [56] 1957–58 1 899 (40–55) 30 132 (I + D) Int; Q; DH V 195 unknown
USA [57] 1959 336 442 (?) 12 ? (D) Q AP – –
USA [58] 1960 6 763 (>60) 21 99 (D) Q 1–3,5,6, AP 14? unknown
Japan [59]
USA [60]
1965
1966
122 261 (>40)
17 633 (>35)
17
20
183 (D)
149 (D)
Int
Mailed Q
1,3,5,6, A 
1–6, 14, A
7 (2)
35 (2?)
unknown
unknown
Sweden [61] 1967 10 942 (36–75) 30 466 (I + D) Q 1–5 107 unknown
Sweden [62] 1971–75 135 006 (<30–
 
≥
 
60) 20 2368 (I + D) Q; Measure AP
USA [63] 1972–74 1 776 (50–84) 14 54 (I) Int; exam 5,6, AP 2 unknown
USA [64] 1975–80 20 316 (>45) 14 198 (I) Int; Q 1–6, 14, A, AP 13 food items no
USA [65, 66] 1976 13 855 (>25) 6–16 180–225 (I) Q 1–6, soy, A 65 unknown
Norway [67] 1977–83 25 708 (16–56) 12.4 72 (I) FFQ 3–7, AP 80 yes
USA [68] 1978–85 43 432 (>30) 4.6 238 (I) Q A (unknown)* unknown†
USA [69] 1981–85 11 577 (>60) 8 208 (I) Q 1,2, V 59 unknown
USA [70] 1982 1 050 (>65) 11 71 (I) Int A, AP unknown unknown
USA [71] 1982 450 279 (>30) 9 1748 (D) Q 1 unknown unknown
USA [80] 1992 86 404 (50–74) 6.5 3739 (I) FFQ dairy, supplements 68 yes
 
Notes as for Table 2, except; CA, college attendants; Int, interview; *Questions on current and past consumption, number of drinks consumed per day, and the type 
of alcoholic beverage; †Data compared closely to data from 7-day recall.
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association with prostate cancer risk, which 
was positive [82]. Tea was only reported in one 
study, and showed no association for black 
tea and a borderline significant increase in 
risk for green tea [24].
Ten studies were identified in which the 
relation between consumption of alcoholic 
beverages and prostate cancer risk was 
investigated. Overall consumption of alcohol 
was not associated with risk of prostate 
cancer in six studies [24,43,64,68,70,82], but 
was associated with an increased risk in two 
[55,59] and a decreased risk in one study [66]. 
Whereas specific types of alcoholic beverages 
were not associated with risk of prostate 
cancer in most studies [59,60,82], one showed 
a negative association for alcohol from beer, 
but significant positive associations for 
alcohol from wine, white wine and fortified 
wines; the only study investigating red wine 
showed no association [43].
Table 7 presents results from prospective 
cohort studies on anthropometric variables, 
e.g. height, weight and body mass index (BMI) 
in relation to the risk of prostate cancer. In all, 
19 positive, 24 null and three negative 
associations were reported between 
anthropometric variables and prostate cancer 
 
TABLE 4 
 
Effect of nutrient supplementation on prostate cancer risk from the results of intervention studies, and the relationship between nutrients and prostate 
cancer risk from prospective cohort studies using biomarkers in blood (or toenails if indicated) as a measure of exposure
 
Exposure
Effect estimate 
<0.80 0.80–1.20 >1.20 
Item estimate [ref]* Item estimate [ref] Item estimate [ref]
 
Intervention (supplements)
 
Vitamins
 
b
 
-carotene
vitamin E
0.68†‡ [13]
0.68† [16]
 
b
 
-carotene
 
b
 
-carotene
1.20 [16], 1.0 [12,14]
1.01 [17]
 
b
 
-carotene 1.33¶ [13]
Selenium selenium 0.37† [15] + retinol
 
Cohort
 
Vitamins A
retinol
0.42† [27]
0.40 [26], CL [28]
retinol
carotenes
NS [20]
0.92 [36]
retinol 1.56 [46], 1.48 [36],
1.4 [25], 3.0 [21], CH [19]
 
a
 
-carotene 0.77 [46]
 
b
 
-carotene 1.08 [26] carotenoids CH [19]
lycopene 0.75/0.57§ [46], 0.50 [26]
 
b
 
-cryptoxanthin 0.80 [46]
 
b
 
-carotene 5.0† [25]
D (1,25-OHD) CL† [29] lutein 1.10 [46]
E 0.60 [23], CL [19] C 0.93 [36]
 
a
 
-tocopherol 0.65 [48] D [25-OHD] 0.92 [34], CS [29]
 
g
 
-tocopherol 0.19† [48] D [1,25-OHD]
E
 
a
 
-tocopherol
0.88 [34]
1.00 [26]
1.06 [46]
Selenium [blood] CL [28], 0.3 [21] selenium [blood] NS [40]
[toenails] 0.58 [48], 0.49† [41], 0.63† [52]
Fat and fatty acids
n-6 PUFA 0.7 [39] total 0.87 [24] saturated 1.6 [39]
stearic 0.35 [32] total fatty acids 1.1 [39], 1.05 [30]
 
∞
 
monounsaturated 1.3 [39]
arachidic 0.7 [39] saturated 1.00 [24] myristic 1.8† [39]
docosanoic 0.7 [39] unsaturated 1.09 [24] palmitic 2.3† [39]
tetracosanoic 0.5† [39] polyunsaturated 1.1 [39] stearic 1.3 [39]
tetracosenoic 0.7 [39] n-6 fatty acids NA [35] oleic 1.8† [39], 1.50 [32]
linoleic 0.62 [32] n-3 fatty acids NA [35] palmitoleic 2.8† [39]
docosapentaenoic 0.7 [39] n-3 PUFA
palmitic
linoleic
dihomo-
 
g
 
-linoleic
arachidonic
eicosenoic
eicosadienoic
eicosapentaenoic
docosahexaenoic
1.1 [39]
0.90 [32]
0.9 [39]
1.1 [39]
0.8 [39]
1.2 [39]
1.0 [39]
1.2 [39], 0.87 [32]
1.0 [39]
arachidonic
 
a
 
-linolenic
1.36 [32]
2.0† [39], 2.14 [32]
 
*Effect estimates for active vs placebo group (intervention studies) or for highest vs lowest exposure category (cohort studies); †denotes statistically significant 
finding. In patient quartile with ‡lowest or ¶highest baseline plasma 
 
b
 
-carotene levels. CL, cases with lower blood levels than controls; CS, cases with similar blood 
level to controls; CH, cases with higher blood level than controls; NA, not associated; §Adjusted for assignment to 
 
b-
 
carotene treatment or placebo; 
 
∞
 
triglycerides, 
mmol/L; PUFA, polyunsaturated fatty acids; NS, not significantly associated.
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risk. In four studies a there was a statistically 
significant positive association between 
height and prostate cancer risk [37,62,64,77], 
whereas in four others there was no 
association [30,53,54,68,70]. Weight showed 
either positive [31,57,58,62,70] or null 
associations [53,64,68]. There were positive 
associations between BMI at baseline and 
prostate cancer risk in four studies 
[22,30,67,70] whereas six showed no 
association [49,62,63,66,68,77]; two showed a 
positive association for BMI when young 
adults (20–25 years) [49,70], but a third 
showed no effect [77]. An increase in BMI 
when aged 25–65 years (reflecting weight 
gain over this period) was negatively 
associated with prostate cancer risk in two 
studies [49,70], but not associated in a 
third [54]. Some other measures of body 
fat distribution, e.g. lean body mass, 
thickness of skinfolds or waist/hip 
circumference, were investigated with 
either null [22,49,53,62,77] or positive [54] 
associations.
Only a few of all prospective studies 
investigated latent and nonlatent or 
advanced prostate tumours separately 
[24,29,32,39,43,44,49,64,70,72,74,77–79,83]. 
For some risk factors, e.g. vitamin D [29], total 
fat, mono-unsaturated fat and 
 
a
 
-linolenic 
acid [79], meat [74], red meat [45], reported 
associations were stronger for advanced or 
aggressive prostate tumours, whereas for fish, 
a negative association was reported for 
metastatic prostate cancer. For other risk 
factors like carotenoids [78], fat and fatty 
 
TABLE 5 
 
Relation between nutrients and prostate cancer risk from prospective cohort studies using dietary questionnaires or interviews to measure exposure
 
Exposure
Effect estimate 
<0.80 0.80–1.20 >1.20 
Item estimate [ref]* Item estimate [ref] Item estimate [ref]
Vitamins A (supp) 0.65 [51] A 1.13 [78], 1.1 [60] retinol 1.32† [78]
lycopene 0.79† [78] A (supp) 1.13 [69]
 
b
 
-cryptoxanthin 1.45† [51]
retinol 0.93 [51], 1.2 [60] C 1.22 [51], 1.27 [56]
E (supp) 0.71 [51]
 
a
 
-carotene
 
b
 
-carotene
lycopene
 
b
 
-cryptoxanthin
lutein
lutein/zeaxanthin
C
C (supp)
D
E
E (supp)
0.85 [51], 1.09 [78]
1.07 [51], 1.05 [78], 1.09 [69],
0.9 [60]
0.94 [73], 1.03 [56]
0.94 [78], 1.03 [56]
1.10 [78]
0.91 [51]
1.09 [78], 0.96 [69]
1.00 [69], 0.83 [51]
0.8 [47], NA†† [80]
0.95 [51], NS [40], 0.94 [78]
1.05 [75], NS [40], 1.00 [69]
Calcium Calcium
Calcium (supp)
1.09 [45], 1.1 [47], 1.2† [80]
1.1 [80]
Calcium
Calcium (diet)
Calcium (dairy prod)
1.71 [76]
1.6† [80]
1.34† [50]
Protein Protein
Protein, vegetable
Protein, animal
1.0 [47], 1.09 [45]
0.92 [45]
1.16 [45]
Fat saturated 0.7 [67] total fat 1.11 [44], 1.1 [47] total fat 1.32 [79], 1.3 [67]
linolenic acid 0.76 [44] total fatty acids
saturated fat
linoleic
poly UFA
trans UFA
cis UFA
palmitic
stearic
linoleic
arachidonic
eicosapentaenoic
docosahexaenoic
1.15 [44]
0.84 [79]
0.88 [79]
0.80 [44]
1.01 [44]
0.89 [44]
1.16 [44]
1.17 [44]
0.80 [44]
1.20 [44]
1.01 [44]
1.05 [44]
saturated FA
MU fat
MUFA
polyunsaturated fat
animal fat
oleic
 
a
 
-linolenic
1.23 [44]
1.4 [67], 1.86 [79]
1.22 [44]
1.4 [67]
1.35 [66]
1.30 [44]
1.25 [79]
Carbohydrate fructose 0.77 [76] carbohydrate
fructose
1.1 [47]
1.0 [47]
 
Notes as for Table 4. UFA, unsaturated fatty acids; MU, monounsturated; FA, fatty acids; supp, supplement; ††Advanced prostate cancer (Stages C and D).
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TABLE 6 
 
Foods and alcohol in relation to prostate cancer risk from prospective cohort studies using questionnaires or interviews to measure exposure
 
Exposure
Effect estimate 
<0.80 0.80–1.20 >1.20 
Item estimate [ref]* Item estimate [ref] Item estimate [ref]
 
Vegetables, 
pulses
 
vegetables 0.79† [71], 0.7 [60] vegetables 0.8 [47], 0.82 [42], 1.04 [78], cruciferous 1.3 [60]
green salads 0.68 [66] 1.04 [69] fried vegetables 1.40 [24]
tomatoes 0.74† [78], 0.60† [66] dark green 1.19 [69] cooked spinach 1.22 [78]
tomato sauce 0.75† [73] mixed 0.96 [78] raw spinach 1.31 [78]
beans/lentils/peas 0.53† [66] green-yellow 1.03 [59]
pulses 0.69† [42] yellow 0.96 [69]
soy milk 0.3† [65] prepared
raw
raw leafy
prepared leafy
carrots
Brassicas
broccoli
tomatoes
tomato juice
Alliums
Fruits & veg
0.85 [42]
1.04 [42], 1.1 [64]
1.10 [42]
0.97 [42]
1.06 [78]
0.82 [42]
1.05 [78]
1.00 [42]
1.11 [42]
0.90 [42]
1.05 [42], 1.15 [82], 1.10 [69]
 
Fruit
 
fruit 0.63† [78] fruit 0.84 [78], 1.04 [69], 0.9 [60], 
1.07 [66], NA [58]
fruit 1.30 [42], 1.3 [47], 
1.57 [24]
fresh winter fruit 0.73 [66] citrus fruit 1.27 [42]
raisins/dates/dried fruit 0.62 [66] fresh fruit
fresh citrus fruit
canned/frozen fruit
oranges
strawberries
1.0 [64]
0.88 [66]
0.82 [66]
0.94 [78]
0.80 [78]
 
Cereals
 
cereals 1.2 [47]
 
Meat
 
meat 0.4 [67] meat 0.95 [24], 0.8 [60], 0.90 [74] meat 1.45 [59]
chicken no skin 0.73
 
‡
 
 [74] poultry 1.1 [64], 0.9 [60] meat or poultry 1.3 [58]
red meat 0.7 [47] fresh meat/poultry 1.01 [45] meat/poultry/fish 1.41 [66]
beef 0.58 [82] chicken with skin
red meat
hamburger
beef hamburger
beef steak
hot dogs
ham/bacon/sausage
sausage
frankfurter/sausage
pork
processed meats
fish and poultry
1.20‡ [74]
0.92 [74]
1.13‡ [74]
1.07 [66]
0.81 [66]
0.89‡ [74]
1.11 [24]
0.82 [82]
NA [67]
1.15 [82], 1.1 [64]
1.2 [64]
1.2 [47]
poultry
red meat
beef/pork/lamb 
beef
hamburger/meatball
bacon
processed meats
cured meat
fat animal products
liver
1.34 [66]
1.72†‡ [74], 2.5 [32]
1.47 [74], 2.51 [32]
1.6† [64], 1.21 [66]
3.1† [67]
1.39‡ [74]
1.44‡ [74]
1.32 [45]
1.6 [64]
1.28 [78]
 
Fish
 
fish
 
0.6 [61], 0.54 [59]
 
fish
 
0.91 [72], 1.06 [45], NA [67], 
0.99 [82], 1.2 [64], 0.8 [60]
fish 1.22 [24], 1.57 [66]
 
Milk, dairy
 
dairy
milk/milk products
milk
whole milk
cottage/ricotta
cream cheese
1.1 [80], 1.04 [74], 1.1 [47],  
NA [32], 1.0 [60]
1.09 [45]
NA [78], 1.00 [24], 0.84 [82], 
1.08 [59]
0.80 [66], 0.9 [63]
1.06‡ [74]
1.20‡ [74]
dairy products
milk
whole
skim vs whole
skim or low-fat
cheese
other cheese
butter
butter/margarine/
cheese
ice-cream
1.36 [50]
1.4 [64], 1.5 [58]
1.25‡[74]
2.2† [67]
1.25‡[74]
1.26 [45], 1.4 [58]
1.29‡ [74]
1.42†‡ [74]
1.47 [24]
1.28 [74], 1.31 [24]
 
Eggs
 
eggs 0.76 [66] eggs 0.96 [45], NA [67, 78], 0.85 [82],
1.1 [64], 0.9 [60], 1.0§ [63]
eggs 1.57 [24], 1.3 [58]
 
Coffee, tea
 
coffee
black tea
0.92 [24], 1.1 [64], 1.0 [60]
0.83 [24]
coffee
green tea
1.91 [82]
1.47† [24]
 
Alcohol
 
alcohol
alcohol from beer
0.71 [66]
0.5 [43]
alcohol 1.2 [43], 1.0 [70], 1.09 [24], 
0.89 [82], 1.0 [68] alcohol 1.38 [59]
spirits 0.78 [82] lifetime ethanol
beer
alcohol from red wine
wine
liquor
alcohol from liquor
1.1 [64]
0.84 [82], 0.94 [59], 1.2 [60]
1.0 [43]
1.18 [82]
1.0 [60]
1.2 [43]
alcohol from wine
alcohol from white wine
alcohol from fortified wines
alcohol abusers
shochu
2.3 [43]
3.4† [43]
2.5† [43]
1.4† [55]
2.34† [59]
 
‡Risk of metastatic prostate cancer.; ¶Per cup per day; §Per egg per week. Other notes as for Table 4.
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acids [44], vegetables and fruit [42], fried 
vegetables and fruit [24], beef and high-fat 
animal products [64], milk and eggs [24,45], 
alcohol [43] and BMI [49,70], reported 
associations were either similar in subgroups 
based on tumour characterization, or were 
inconsistent among studies.
 
DISCUSSION
 
We present an overview of the 
epidemiological evidence on the potential role 
of dietary factors in the aetiology of prostate 
cancer. This review was restricted to 
prospective studies for two reasons; first, 
results of case-control studies were 
inconclusive [11,84] and second, such studies 
are prone to both selection and information 
bias. In all, 41 studies (37 cohort, four 
intervention) published until September 2003 
were included. Given the high incidence of 
prostate cancer and the largely unknown 
causes of the disease, it seems probable that 
any findings on possible risk factors would be 
published; therefore, the possibility of 
publication bias is less likely. Furthermore, to 
minimize this type of bias, qualitative findings 
mentioned in publications (i.e. with no effect 
estimates) were also included in the review.
Before discussing the specific findings two 
drawbacks must be noted; first, despite 
considerable research efforts over the past 
decades, the available evidence for many 
individual foods and nutrients, e.g. specific 
fatty acids, types of vegetables and fruits, 
alcoholic beverages, processed meats, specific 
dairy products, etc., remains limited, which 
hampers firm conclusions on such foods 
or nutrients at present. Second, for several 
foods or food groups for which more 
information is available, this review shows 
no or inconsistent associations with 
prostate cancer risk. In the absence of a 
true association, random variation may lead 
to some studies with false-positive (RR > 1) 
and some studies with false-negative (RR < 1) 
associations, which are evenly distributed 
around RR 
 
ª
 
 1. However, inconsistent results 
of different studies may also be caused by 
heterogeneity in study size, outcome 
measures, duration of follow-up, 
extensiveness of dietary evaluation, and 
identification of potential confounders. Some 
of these factors will be briefly discussed 
below.
Many studies were small; 38% included <100 
cases; 43% used prostate cancer mortality, or 
a combination of incidence and mortality, as 
an endpoint. In general, in aetiological studies 
incidence is a more appropriate endpoint than 
mortality, as mortality is determined by 
many factors, including tumour stage and 
oncological treatment. In only five studies 
was the validation of dietary questionnaires 
reported; the relatively crude dietary exposure 
information collected by questionnaires/
interviews in the remaining studies may have 
resulted in random misclassification of dietary 
exposure to different foods and nutrients. 
Inadequacies in food composition tables 
are another potential source of error in 
questionnaire-based studies. Although several 
studies used blood samples as a biomarker 
of long-term dietary intake, this method is 
also limited by the short half-life of several 
nutrients (e.g. vitamin C) and between-subject 
variability in the absorption, metabolism and 
excretion of nutrients. Generally, random 
misclassification of exposure could have 
 
TABLE 7 
 
Relation between anthropometric measures and prostate cancer risk from prospective cohort studies
 
Exposure
Effect estimate 
<0.80 0.80–1.20 >1.20 
Item estimate [ref]* Item estimate [ref] Item estimate [ref]
Height, weight,
BMI, LBM
BMI
change in BMI
from age 25 
to >65
0.7 [64]
0.61 [49], 
0.7 [70]
height
sitting height
weight
BMI
Ponderal index
BMI at age 21
change in BMI during
life
LBM
triceps skinfold 
thickness
waist circumference
hip circumference
0.97 [49], 1.14† [62], 1.1 [70],
0.99‡ [30], NA [53, 54, 68]
0.94 [22]
1.16† [62], 0.9 [64], NA [53, 68]
0.85 [49], 0.90 [77] , 1.13 [62],
NA [68], 1.17 [66] 1.1¶ [63]
NA [53]
0.87 [77]
NA [54]
0.96 [49], 1.17 [62]
0.94 [22]
0.99 [77]
0.85 [77]
height
leg length
weight
BMI
BMI at age 20
BMI at age 25 
BMI at age 50
BMI change 50 to >65
girth left upper arm
scapular skinfold 
thickness
biacromial diam
1.37† [77], 1.27† [37],
1.8† [64]
1.24 [22]
1.6 [70], 1.52† [31], 
1.29 [57], 2.4† [58]
1.5 [70], 1.33 [22], 
2.2† [67], 1.25† [30]
1.34 [49]
1.4 [70]
1.3 [70]
1.3 [70]
1.49 [22]
1.27 [22]
1.22 [22]
 
‡Per 10 cm; ¶ Per 2.92 kg/m2. Other notes as for Table 4; BMI, Body Mass Index; LBM, Lean Body Mass.
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resulted in underestimation of true positive/
negative associations between diet and 
prostate cancer risk.
Another potential cause of inconsistent 
results of different studies is bias by 
confounding. As only a minority of the 
prospective studies had an extensive dietary 
assessment, controlling for potential 
confounding by other dietary components 
was not possible in most cases. However, for 
 
ª
 
15 publications reporting both crude and 
multivariate adjusted Risk ratios, we 
compared these values. In virtually all cases, 
RRs changed only marginally after 
multivariate adjustment, indicating that 
confounding did not play a major role.
Inconsistent results between studies may well 
be caused by differences in study population 
between countries, e.g. the USA, Finland and 
the Netherlands. For instance, in the USA, 
many foods are fortified with vitamins, 
leading to a different food matrix when 
compared with studies in Finland or the 
Netherlands. Also, that three of four 
intervention studies were in high-risk groups 
or smokers may impede extrapolation to the 
general population. Finally, differences in 
aetiology between latent and clinically 
apparent or advanced/aggressive prostate 
tumours may have influenced the reported 
associations between dietary factors and 
prostate cancer risk, an issue which was not 
addressed in most studies.
Nevertheless, considering all these limitations, 
the main findings of this review can be 
summarized as follows.
• Although overall consumption of meat and 
fish appears to be unrelated to prostate 
cancer risk, most studies show either null or 
positive associations for different types of 
meat, and this also applies to milk and dairy 
products. For eggs, most studies suggest no 
relationship with prostate cancer risk.
• A potential protective effect of vegetables 
is supported by only two of six studies, 
whereas four show no relation. Although data 
on pulses are limited, all three available 
cohort studies consistently show a protective 
effect. Furthermore, three out of four cohort 
studies support a protective role for 
tomatoes/tomato sauce. Cruciferous 
vegetables and alliums (onion, leek, etc.) 
appear to be unrelated to prostate cancer risk.
• Overall fruit consumption is not associated 
with prostate cancer risk in five studies, but 
with an increased risk in three and a reduced 
risk in one. Of individual fruits, only dried fruit 
is associated with reduced risk in one study 
[66].
• As for vitamin A and carotenoids, four 
intervention studies consistently failed to 
show any protective effect of 
 
b
 
-carotene on 
prostate cancer; two studies show no effect, 
one an insignificant increase, and one a 
reduction in subjects with low serum levels of 
 
b
 
-carotene at baseline, but an increase in 
subjects with high baseline serum 
 
b
 
-carotene 
levels. Cohort studies also show no consistent 
associations of vitamin A and carotenoids 
with prostate cancer risk, except for lycopene: 
two plasma-based and one questionnaire-
based cohort studies of lycopene suggest a 
negative association, but this relation was not 
detected in two other questionnaire-based 
studies.
• For vitamin E, one intervention study [16] 
indicates a reduction of prostate cancer risk 
by vitamin E supplementation. This is 
supported by three serum-based cohort 
studies, but not by a fourth, nor by 
questionnaire-based studies of vitamin E 
intake from food or supplements. Data on 
vitamins C and D show no consistent effect.
• Selenium shows protective effects in one 
intervention study [15]; this is consistent with 
a 
 
ª
 
50% risk reduction by high vs low 
selenium in toenails or blood in five of six 
cohort studies. For calcium, although two 
cohort studies show no association, two other 
studies show an increased prostate cancer risk 
at high intake (2000 mg/day); there were 
independent associations for calcium from 
foods and supplements.
• For fat, most associations reported in five 
cohort studies are null or positive. For total fat 
(or total fatty acids), three serum-based 
studies show no effect; in contrast, four 
questionnaire-based studies show RRs of 
1.1–1.3, suggesting a slightly increased risk of 
prostate cancer for subjects with high fat 
consumption. For individual fatty acids, data 
are highly inconsistent, except an elevated 
risk (RR = 1.2–2.8) for mono-unsaturated 
fatty acids (including oleic and palmitoleic 
acid) in two studies.
• Three of four studies on coffee 
consumption show no association with 
prostate cancer risk, but one an increased risk. 
The only study on tea consumption does not 
suggest a relationship with prostate cancer 
risk.
• Studies on alcohol consumption show, 
again, no consistent relation between overall 
alcohol consumption and risk of prostate 
cancer. For individual alcoholic beverages, 
most studies show a either null association or 
an increased risk.
• Findings for anthropometric variables 
suggest either a null or a positive association 
of height, BMI and other anthropometric 
variables with prostate cancer risk.
In conclusion, this review of prospective 
studies on diet and prostate cancer risk 
indicates a protective effect for selenium; 
other potentially protective foods/nutrients 
may be vitamin E, pulses and tomatoes/
lycopene. Overall consumption of meat and 
consumption of eggs, vegetables, fruit, coffee, 
tea, carotenoids, and the vitamins A, C and D 
show no consistent relations with prostate 
cancer risk. For specific types of both meat 
and alcoholic beverages, as well as for fat and 
dairy products, mostly null or positive 
associations are reported; this also applies to 
anthropometric measures. Furthermore, two 
cohort studies suggest that very high calcium 
intake (> 2000 mg/day) may be associated 
with increased prostate cancer risk.
Future research on dietary risk factors for 
prostate cancer should be based on an 
extensive exposure measurement including 
information on both dietary and non-dietary 
risk factors. With time the increasing numbers 
of cases will increase the reliability of 
findings, and allow subgroup analyses.
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